A European Medicines Agency (EMA) committee said on Friday it has started a review of decongestant medicines for cold and flu that contain the ingredient pseudoephedrine following safety concerns.
The EMA said the review was due to reports of conditions affecting blood vessels in the brain in some patients who took pseudoephedrine-containing medicines.
Pseudoephedrine is a drug that is used alone or in combination with other medicines to treat a blocked nose due to cold, flu or allergy.
Makers of pseudoephedrine-containing drugs include Reckitt Benckiser, McNeil Products Ltd and Organon & Co.
(Reporting by Sriparna Roy in Bengaluru; editing by Shounak Dasgupta)
Topics Europe
Was this article valuable?
Here are more articles you may enjoy.
Rivian Agrees to Pay $250 Million to Settle IPO Fraud Lawsuit 
GEICO Sues Medical Firms in Florida, NY Over Alleged No-Fault Auto Fraud 
Suspects in Louvre Heist in Custody After Week-Long Manhunt 
‘Massive Legal Siege’ Against Social Media Companies Looms 
